Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Carcinogenesis|August 1, 1988
Structure-activity relationships for epidermal ornithine decarboxylase induction and skin tumor promotion by anthronesJ DiGiovanni, F H Kruszewski, M M Coombs, et al.
Cancer Research|April 1, 1986
Bay region distortions in cyclopenta[a]phenanthrenesS Kashino, D E Zacharias, R M Peck, et al.
Drug Discovery Today|September 8, 2001
Effective decision-making: progressing compounds through clinical developmentC A. Shillingford, C W. Vose
Carcinogenesis|September 1, 1988
Synthesis and biological activity of some further cyclopenta[a]phenanthrenesT S Bhatt
Carcinogenesis|January 1, 1986
Comparison of the metabolism and DNA binding of the carcinogen 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one by hamster embryo cells and the human hepatoma cell line HepG2T S Bhatt
Mutation Research|January 1, 1982
Attempts to initiate skin tumours in mice in the 2-stage system using 4-chloromethylbiphenyl (4CMB), 4-hydroxymethylbiphenyl (4HMB), and benzyl chloride (BC). Report of the experiment at 10 monthsM M Coombs
Carcinogenesis|January 1, 1982
The influence of various enzyme inducers on the microsomal metabolism of 7,8-benzoflavoneM M Coombs
Biomedical Mass Spectrometry|April 1, 1984
Identification of a plasma metabolite of 5-(2-bromo-E-ethenyl)-2'-deoxyuridineY Robinson, N Gerry, R D Brownsill, et al.
Biomedical Mass Spectrometry|February 1, 1977
Mass spectrometry of cyclopenta[alpha]phenanthrenes. Metabolites formed in vitro and in vivo from the carcinogen 15,16-dihydro-11-methyl-cyclopenta[alpha]phenanthren-17-oneC Vose, M M Coombs
Carcinogenesis|January 1, 1981
DNA adducts of the carcinogen, 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, in vivo and in vitro: high pressure liquid chromatographic separation and partial characterizationP J Abbott, M M Coombs
Pageof 7